June L Fung1, Terryl J Hartman2, Rosemary L Schleicher3, Marlene B Goldman4. 1. Department of Obstetrics and Gynecology, Dartmouth-Hitchcock Medical Center and Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire. Electronic address: june.y.fung@gmail.com. 2. Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, Georgia. 3. Division of Laboratory Sciences, National Center for Environmental Health, Centers for Disease Control and Prevention, Atlanta, Georgia. 4. Department of Obstetrics and Gynecology, Dartmouth-Hitchcock Medical Center and Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire; Community and Family Medicine, Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire.
Abstract
OBJECTIVE: To evaluate the role of vitamin D intake and serum levels on conception of clinical pregnancy and live birth. DESIGN: Prospective cohort study. SETTING: Academic medical centers. PATIENT(S): Healthy, nulliparous women, age 18-39 years, and their male partners. INTERVENTION(S): None. MAIN OUTCOME MEASURE(S): Clinical pregnancy and live birth were compared between those who did or did not meet the vitamin D estimated average requirement (EAR) intake (10 μg/d) and with serum 25-hydroxyvitamin D (25(OH)D) considered at risk for inadequacy or deficiency (<50 nmol/L) or sufficient (≥50 nmol/L). RESULT(S): Among 132 women, 37.1% did not meet the vitamin D EAR and 13.9% had serum levels at risk for inadequacy or deficiency. Clinical pregnancies were significantly higher among women who met the vitamin D EAR (67.5% vs. 49.0%) and with sufficient serum 25(OH)D (64.3% vs. 38.9%) compared with those who did not. Live births were higher among those who met the vitamin D EAR (59.0% vs. 40.0%). The adjusted odds ratio (AOR) of conceiving a clinical pregnancy was significantly higher among those who met the EAR (AOR = 2.26; 95% confidence interval [CI], 1.05-4.86) and had sufficient serum 25(OH)D (AOR = 3.37; 95% CI, 1.06-10.70). The associations were not significant after controlling for selected nutrients and dietary quality. CONCLUSION(S): Women with vitamin D intake below EAR and serum 25(OH)D levels at risk for inadequacy or deficiency may be less likely to conceive and might benefit from increased vitamin D intake to achieve adequacy. CLINICAL TRIAL REGISTRATION NUMBER: NCT00642590.
OBJECTIVE: To evaluate the role of vitamin D intake and serum levels on conception of clinical pregnancy and live birth. DESIGN: Prospective cohort study. SETTING: Academic medical centers. PATIENT(S): Healthy, nulliparous women, age 18-39 years, and their male partners. INTERVENTION(S): None. MAIN OUTCOME MEASURE(S): Clinical pregnancy and live birth were compared between those who did or did not meet the vitamin D estimated average requirement (EAR) intake (10 μg/d) and with serum 25-hydroxyvitamin D (25(OH)D) considered at risk for inadequacy or deficiency (<50 nmol/L) or sufficient (≥50 nmol/L). RESULT(S): Among 132 women, 37.1% did not meet the vitamin D EAR and 13.9% had serum levels at risk for inadequacy or deficiency. Clinical pregnancies were significantly higher among women who met the vitamin D EAR (67.5% vs. 49.0%) and with sufficient serum 25(OH)D (64.3% vs. 38.9%) compared with those who did not. Live births were higher among those who met the vitamin D EAR (59.0% vs. 40.0%). The adjusted odds ratio (AOR) of conceiving a clinical pregnancy was significantly higher among those who met the EAR (AOR = 2.26; 95% confidence interval [CI], 1.05-4.86) and had sufficient serum 25(OH)D (AOR = 3.37; 95% CI, 1.06-10.70). The associations were not significant after controlling for selected nutrients and dietary quality. CONCLUSION(S): Women with vitamin D intake below EAR and serum 25(OH)D levels at risk for inadequacy or deficiency may be less likely to conceive and might benefit from increased vitamin D intake to achieve adequacy. CLINICAL TRIAL REGISTRATION NUMBER: NCT00642590.
Authors: M Shahbazi; M Jeddi-Tehrani; M Zareie; A Salek-Moghaddam; M M Akhondi; M Bahmanpoor; M R Sadeghi; A H Zarnani Journal: Placenta Date: 2011-07-18 Impact factor: 3.481
Authors: G Parikh; M Varadinova; P Suwandhi; T Araki; Z Rosenwaks; L Poretsky; D Seto-Young Journal: Horm Metab Res Date: 2010-08-13 Impact factor: 2.936
Authors: Briana J Rudick; Sue Ann Ingles; Karine Chung; Frank Z Stanczyk; Richard J Paulson; Kristin A Bendikson Journal: Fertil Steril Date: 2013-11-05 Impact factor: 7.329
Authors: E Wehr; S Pilz; N Schweighofer; A Giuliani; D Kopera; T R Pieber; B Obermayer-Pietsch Journal: Eur J Endocrinol Date: 2009-07-23 Impact factor: 6.664
Authors: Sunni L Mumford; Rebecca A Garbose; Keewan Kim; Kerri Kissell; Daniel L Kuhr; Ukpebo R Omosigho; Neil J Perkins; Noya Galai; Robert M Silver; Lindsey A Sjaarda; Torie C Plowden; Enrique F Schisterman Journal: Lancet Diabetes Endocrinol Date: 2018-05-31 Impact factor: 32.069
Authors: Alexandra C Purdue-Smithe; Keewan Kim; Carrie Nobles; Enrique F Schisterman; Karen C Schliep; Neil J Perkins; Lindsey A Sjaarda; Joshua R Freeman; Sonia L Robinson; Jeannie G Radoc; James L Mills; Robert M Silver; Aijun Ye; Sunni L Mumford Journal: Nat Commun Date: 2021-05-13 Impact factor: 14.919
Authors: Y H M Krul-Poel; P P Koenders; R P Steegers-Theunissen; E Ten Boekel; M M Ter Wee; Y Louwers; P Lips; J S E Laven; S Simsek Journal: PLoS One Date: 2018-12-04 Impact factor: 3.240